In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $11.79 in the prior trading day, Niagen Bioscience Inc (NASDAQ: NAGE) closed at $11.3, down -4.16%. In other words, the price has decreased by -$4.16 from its previous closing price. On the day, 0.93 million shares were traded. NAGE stock price reached its highest trading level at $11.9 during the session, while it also had its lowest trading level at $11.28.
Ratios:
Our goal is to gain a better understanding of NAGE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 45.65. For the most recent quarter (mrq), Quick Ratio is recorded 3.12 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on May 27, 2025, initiated with a Buy rating and assigned the stock a target price of $13.
B. Riley Securities Downgraded its Buy to Neutral on August 11, 2022, whereas the target price for the stock was revised from $6 to $2.40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 07 ’25 when Lopez Carlos Luis bought 273 shares for $7.86 per share. The transaction valued at 2,146 led to the insider holds 2,251 shares of the business.
Jaksch Frank L Jr sold 37,161 shares of NAGE for $229,956 on Dec 13 ’24. The Director now owns 244,179 shares after completing the transaction at $6.19 per share. On Dec 13 ’24, another insider, Frank Jaksch Jr., who serves as the affiliate of the company, bought 37,161 shares for $6.19 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAGE now has a Market Capitalization of 890097600 and an Enterprise Value of 1085537280. As of this moment, Niagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 65.43, and their Forward P/E ratio for the next fiscal year is 47.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.34. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.25 while its Price-to-Book (P/B) ratio in mrq is 16.01. Its current Enterprise Value per Revenue stands at 10.058 whereas that against EBITDA is 77.417.
Stock Price History:
The Beta on a monthly basis for NAGE is 2.16, which has changed by 3.0794225 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, NAGE has reached a high of $14.69, while it has fallen to a 52-week low of $2.52. The 50-Day Moving Average of the stock is -2.26%, while the 200-Day Moving Average is calculated to be 54.81%.
Shares Statistics:
The stock has traded on average 961.30K shares per day over the past 3-months and 1283520 shares per day over the last 10 days, according to various share statistics. A total of 78.43M shares are outstanding, with a floating share count of 49.81M. Insiders hold about 36.77% of the company’s shares, while institutions hold 31.95% stake in the company. Shares short for NAGE as of 1749772800 were 3272948 with a Short Ratio of 3.72, compared to 1747267200 on 2199371. Therefore, it implies a Short% of Shares Outstanding of 3272948 and a Short% of Float of 6.329999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
